Author
Mikhail V. Blagosklonny
- Indexed works
- 46
- Total citations
- 14,691
- Active years
- 15
Collaborators
Works in the record
Cell Death and Differentiation 2018
Open access · OA
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Cell Death and Differentiation 2011
Open access · OA
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
Cell Death and Differentiation 2009
Open access · OA
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
Cell Cycle 2006
Open access · CC-BY
Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
Cell Cycle 2011
Open access · OA
Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
Aging 2010
Open access · CC-BY
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
American Journal Of Pathology 2010
Open access · OA
Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
Aging 2012
Open access · CC-BY
Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging
Aging 2009
Open access · CC-BY
Growth and aging: a common molecular mechanism
Cell Cycle 2010
Open access · OA
Calorie restriction: Decelerating mTOR-driven aging from cells to organisms (including humans)
Cell Cycle 2009
Open access · OA
Pseudo-DNA damage response in senescent cells
Cell Cycle 2010
Open access · OA
Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program
Aging 2012
Open access · CC-BY
Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
Cell Cycle 2014
Open access · OA
Geroconversion: irreversible step to cellular senescence
Aging 2020
Open access · CC-BY
From causes of aging to death from COVID-19
Cell Cycle 2009
Open access · OA
At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence
Aging 2012
Open access · CC-BY
New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis
American Journal Of Pathology 2012
Open access · OA
Prospective Treatment of Age-Related Diseases by Slowing Down Aging
Aging 2011
Open access · CC-BY
Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression
Cell Cycle 2010
Open access · OA
Rapamycin and quasi-programmed aging: Four years later
Aging 2010
Open access · CC-BY
Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives
Aging 2012
Open access · CC-BY
Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
Aging 2011
Open access · CC-BY
Molecular damage in cancer: an argument for mTOR-driven aging
Oncotarget 2017
Open access · CC-BY
From rapalogs to anti-aging formula
Cancer Biology & Therapy 2012
Open access · OA
Rapalogs in cancer prevention
Cell Cycle 2012
Open access · CC-BY
Suppression of replicative senescence by rapamycin in rodent embryonic cells
American Journal Of Pathology 2012
Open access · OA
Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats
Cancer Biology & Therapy 2014
Open access · OA
Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin
Cell Death and Disease 2019
Open access · CC-BY
Fasting and rapamycin: diabetes versus benevolent glucose intolerance
Cell Death and Disease 2014
Open access · CC-BY
Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
Oncotarget 2023
Open access · CC-BY
Cancer prevention with rapamycin
Cell Cycle 2022
Open access · CC-BY
Cell senescence, rapamycin and hyperfunction theory of aging
Aging 2016
Open access · CC-BY
Gerosuppression by pan-mTOR inhibitors
Aging 2010
Open access · CC-BY
Why human lifespan is rapidly increasing: solving "longevity riddle" with "revealed-slow-aging" hypothesis
GeroScience 2023
Open access · OA
Evaluation of off-label rapamycin use to promote healthspan in 333 adults
Cell Cycle 2011
Open access · OA
Rapamycin-induced glucose intolerance: Hunger or starvation diabetes
Cell Death and Disease 2010
Open access · CC-BY
Linking calorie restriction to longevity through sirtuins and autophagy: any role for TOR
Cell Cycle 2010
Open access · OA
Increasing healthy lifespan by suppressing aging in our lifetime: Preliminary proposal
Aging 2011
Open access · CC-BY
Progeria, rapamycin and normal aging: recent breakthrough
Cell Death and Disease 2013
Open access · CC-BY
Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet
Cell Death and Disease 2014
Open access · CC-BY
Koschei the immortal and anti-aging drugs
Oncotarget 2021
Open access · CC-BY
Anti-aging: senolytics or gerostatics (unconventional view)
Oncotarget 2012
Open access · CC-BY
Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions
Aging 2009
Open access · CC-BY
Inhibition of S6K by resveratrol: In search of the purpose
Aging 2022
Open access · CC-BY
Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) 2018
Preprint · OA